- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03593161
Humor Therapy and Distress After Allogeneic Stem Cell Transplantation
The Effect of Humor Therapy on Perceived Distress After Allogeneic Stem Cell Transplantation
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Patients undergoing allo-HSCT often experience substantial psychological distress during hospitalization and after discharge. Research in pediatric patients with cancer as well as geriatric patients suggests that psychosocial burden might be decreased by humor therapy. Studies addressing the impact of humor therapy in adult patients with cancer are lacking.
This randomized controlled trial primarily aims at assessing the effect of therapeutic humor on global distress in patients during their hospital stay for allo-HSCT. In addition, the study investigates hope, depressive symptoms, anxiety, and pain as secondary outcomes. The outcomes are measured via questionnaires.
Study results may be beneficial for patients who experience distress during hospitalization for allo-HSCT.
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Nicolaus M. Kröger, Prof. Dr.
- Telefonnummer: +49(0)40-7410-54851
- E-post: bmt@uke.de
Studer Kontakt Backup
- Navn: Angela Scherwath, Dr.
- Telefonnummer: +49(0)40-7410-57565
- E-post: a.scherwath@uke.de
Studiesteder
-
-
-
Hamburg, Tyskland, 20246
- Rekruttering
- University Medical Center Hamburg-Eppendorf
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age ≥ 18 years
- Admission for allogeneic transplantation at the University Medical Center Hamburg-Eppendorf
Exclusion Criteria:
- Insufficient German language skills
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Humor therapy
After baseline assessment (before start of conditioning), patients assigned to the experimental study arm will receive the standard psychosocial care plus weekly clown visits over the course of their inpatient stay for allogeneic stem cell transplantation.
|
Clown visits
|
Ingen inngripen: Treatment as usual
Patients assigned to the control arm will receive the standard psychosocial care over the course of their inpatient stay for allogeneic stem cell transplantation.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Distress
Tidsramme: Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +7, +14, +21 and +28)
|
Measured with the Distress Thermometer (DT): Brief screening instrument to assess the level of perceived distress in patients with cancer (11-point scale ranging from 0 = no distress to 10 = extreme distress)
|
Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +7, +14, +21 and +28)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Hope
Tidsramme: Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +7, +14, +21 and +28)
|
Measured with the Herth Hope Index (HHI): Short self-report instrument for the measurement of hope in clinical oncological care (12 items, 4-point Likert scale ranging from 1 = strongly disagree to 4 = strongly agree)
|
Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +7, +14, +21 and +28)
|
Depressive symptoms
Tidsramme: Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +14 and +28)
|
Measured with the Patient Health Questionnaire-9 (PHQ-9): Short self-report instrument to assess the severity of depressive symptoms (9 items, 4-point Likert scale ranging from 0 = not at all to 3 = nearly every day)
|
Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +14 and +28)
|
Anxiety symptoms
Tidsramme: Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +14 and +28)
|
Measured with the Generalized Anxiety Disorder Scale-7 (GAD-7): Short self-report instrument to assess the severity of anxiety symptoms (7 items, 4-point Likert scale ranging from 0 = not at all to 3 = nearly every day)
|
Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +14 and +28)
|
Pain intensity measured with the Numerical Rating Scale (NRS)
Tidsramme: Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +7, +14, +21 and +28)
|
Measured with the Numerical Rating Scale (NRS): Brief screening instrument to assess pain intensity (11-point scale ranging from 0 = no pain to 10 = worst imaginable pain)
|
Change from baseline (before start of conditioning) to 4 weeks after allogeneic stem cell transplantation (days +7, +14, +21 and +28)
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Nicolaus M. Kröger, Prof. Dr., University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- DJCLS 26R/2017
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Humor therapy
-
Loma Linda UniversityFullført
-
Happy Nation SocietyFullført
-
Second Affiliated Hospital, School of Medicine,...Fullført
-
University Hospital, Strasbourg, FranceFullført
-
Geisinger ClinicFullførtHelsefremmende | Forebygging | Risikoreduksjonsatferd | TelehelseForente stater
-
University Hospital, GenevaFullførtPsykiatrisk lidelse | Behandlingsoverholdelse og etterlevelseSveits
-
Geisinger ClinicFullførtHelsefremmende | Forebygging | RisikoreduksjonsatferdForente stater
-
Johns Hopkins Bloomberg School of Public HealthFullført
-
Institut National de la Santé Et de la Recherche...UkjentChoroidal neovaskularisering | Mineralokortikoid overskudd
-
University of Erlangen-Nürnberg Medical SchoolAvsluttetDepresjon | Livskvalitet | Leukemi | Graft-versus-vertssykdom | Stamcelletransplantasjonskomplikasjoner | Hematologisk neoplasmaTyskland